Inhibiting bone resorption

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/66 (2006.01) A61K 31/00 (2006.01) A61K 31/663 (2006.01) A61K 45/00 (2006.01) A61P 1/04 (2006.01) A61P 3/14 (2006.01) A61P 13/08 (2006.01) A61P 19/00 (2006.01) A61P 19/08 (2006.01) A61P 19/10 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2294595

Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein. The compounds are bisphosphonates selected from the group consisting of alendronate, cimadronate, clodronate, tiludronate, etridronate, ibandronate, risedronate, piridronate, pamidronate, zolendronate, optionally in combination with a histamine H2 antagonist.

L'invention concerne des procédés d'inhibition de résorption osseuse chez les mammifères tout en minimisant l'apparition ou le risque d'effets secondaires gastro-intestinaux. Font aussi l'objet de cette invention les compositions pharmaceutiques et les ensembles permettant de mettre en oeuvre les procédés thérapeutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Inhibiting bone resorption does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibiting bone resorption, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibiting bone resorption will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1990510

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.